Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study.
about
Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity DisorderUnderstanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular functionDifferential cognitive actions of norepinephrine a2 and a1 receptor signaling in the prefrontal cortexCardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.An integrative approach to determine the best behavioral and biological markers of methylphenidate.Cardiovascular events and death in children exposed and unexposed to ADHD agentsBlood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder.A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.Drug therapy of attention deficit hyperactivity disorder: current trends.Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials.Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate.Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?Exposure-response analyses of blood pressure and heart rate changes for methylphenidate in healthy adults.Cardiac autonomic dysfunction and arterial stiffness among children and adolescents with attention deficit hyperactivity disorder treated with stimulants.Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorderLearning and attention problems among children with pediatric primary hypertension.Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder.Hemodynamic effects of acute administration of atomoxetine and methylphenidate.The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology.Cardiac reactivity and stimulant use in adolescents with autism spectrum disorders with comorbid ADHD versus ADHD.
P2860
Q22241421-2C95EC65-F49D-46D2-96D7-7C141FD73A56Q22252308-42F4FD9C-DFAE-4490-99D6-D2397E1BDF2BQ30354144-18BD2BDF-D982-4A26-BBB6-313CE6821C12Q30399107-53E232FF-1466-43CC-801F-5E262FD51924Q30451303-9DA48A97-4EFC-4CC5-A3BB-96C56584DF55Q33283331-14901A76-A7C8-42C7-B641-AFFF5BA610F7Q33901929-5413F20E-B4AD-4D67-8AA2-5F76ABA34FEFQ34045097-0A516947-4BD7-4870-8B0C-6E6F74B6C2C4Q34468658-602487D6-4573-4E9D-A718-14774A3F3DA3Q34650130-27595957-D43C-45E6-838B-F62C79B9E55AQ35964370-1B989ADB-0FC8-4E04-966D-A514D60361F1Q36453293-24C20BF5-0F2B-4BE5-9421-ECECB6CDD686Q37023974-EC16689F-DFB0-4861-A11A-0537C35AE2F8Q38043921-EBB7A938-D8C6-49C6-97E6-41F48062A3A4Q38060572-88CF132B-BF95-4C0E-B7F7-F20F63C9BCA7Q38101134-EC4A9AA5-96A8-427E-916F-88D0B3184C5FQ38242438-CDB60E49-A8D9-4D68-A561-8D0D5DB54BF5Q38953668-1907C8A6-C252-45A4-BF5D-4D327B36CED7Q40207017-DC435A1A-29E5-48D3-9A36-A5DA708AD8BBQ40654140-44D1CB7C-B13B-4D2E-B5EB-4CE88D2B3571Q41576131-CA801B69-D41E-4DB7-8A83-CD9AC1EAD24EQ42671264-0AF82677-3DFC-4D3D-85D5-5D26C9653208Q46542236-F7F284D3-B44D-4D43-9042-FBAA717265DDQ46611647-6F165BF8-DD1C-48C3-9749-737DB6464715Q50310728-32EB4634-C67B-4591-B7A8-024C68D350CF
P2860
Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Effects of once-daily osmotic- ...... om a one-year follow-up study.
@en
Effects of once-daily osmotic- ...... om a one-year follow-up study.
@nl
type
label
Effects of once-daily osmotic- ...... om a one-year follow-up study.
@en
Effects of once-daily osmotic- ...... om a one-year follow-up study.
@nl
prefLabel
Effects of once-daily osmotic- ...... om a one-year follow-up study.
@en
Effects of once-daily osmotic- ...... om a one-year follow-up study.
@nl
P2093
P1476
Effects of once-daily osmotic- ...... om a one-year follow-up study.
@en
P2093
Concerta Study Group
Marc Lerner
Timothy E Wilens
P356
10.1097/01.JCP.0000106223.36344.DF
P407
P577
2004-02-01T00:00:00Z